GlassScriptPhysician profile
Allison M Costa
NPI 1629606835
$1,219.63
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $340 · 2022: $820 · 2023: $30.47 · 2024: $29.72.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $44.92 · Education: $15.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $44.92 |
| Education | $15.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $370.39 | 2021-2023 | |
| Regeneron Healthcare Solutions, INC. | $125.00 | 2021 | |
| Lilly USA, LLC | $120.17 | 2021-2022 | |
| Incyte Corporation | $118.54 | 2021-2024 | Opzelura |
| Janssen Scientific Affairs, LLC | $76.20 | 2021 | |
| Pfizer INC. | $53.67 | 2022-2023 | |
| Ucb, INC. | $48.80 | 2022 | |
| Genzyme Corporation | $46.77 | 2022 | |
| Janssen Biotech, INC. | $41.82 | 2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $38.02 | 2021-2022 | |
| Vyne Pharmaceuticals INC. | $37.41 | 2021 | |
| Sun Pharmaceutical Industries INC. | $34.45 | 2022 | |
| Epi Health, LLC | $27.72 | 2022 | |
| Journey Medical Corporation | $23.21 | 2022 | |
| Leo Pharma INC. | $23.20 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medimetriks Pharmaceuticals, INC. | $21.62 | 2022 | |
| Galderma Laboratories, L.P. | $12.64 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allison Costa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.